ESR1 and ovarian cancer: Molecular and clinicopathological data from The Cancer Genome Atlas Program suggest a correlation between ERα and DOT1L (distuptor of telomeric silencing 1-like) expression and prognosis in ovarian cancers.38 In the study by Salvati et al,39 the key role of DOT1L was demonstrated.